1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Caroline Nilsson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy Omalizumab - Peanut Allergy | Phase 2 | Unknown | Caroline Nilsson | 23 | 2013-10-01 | 2018-08-24 |
Omalizumab (1)
Sweden (1)